The standard management of low-grade lymphoma remains controversial. Long-term follow-up studies of patients treated with conventional regimens have shown that currently available treatments are not curative.
Arturo Molina, MD
Advertisement
Articles by Arturo Molina, MD
Advertisement
Latest Updated Articles
- Clinical Status and Optimal Use of Rituximab for B-Cell Lymphomas
December 1st 1998
Advertisement
Advertisement
Trending on CancerNetwork
1
I-DXd Earns FDA Priority Review in Extensive-Stage Small Cell Lung Cancer
2
Dose Modification Strategies in EGFR Mutated Metastatic Non-Small Cell Lung Cancer
3
Daraxonrasib Shows "Unprecedented" Survival in Pretreated Pancreatic Cancer
4
FDA Receives sBLA for Zenocutuzumab in Advanced NRG1+ Cholangiocarcinoma
5